Deep Genomics services

AI Drives Unprecedented Number of Valuable Medicines by Combining Prediction and Scale. Our proprietary AI Workbench is designed for data-driven prediction, positive feedback loops, and exponential growth. It enables us to identify leads for over 50% of the novel targets we select, and to do so quickly. This is a game changer. In 2018, our proprietary AI Workbench unlocked our first targets in which RNA splicing was the defect and the mechanism for correction. Our AI Workbench 2.0, released in Spring 2020, expanded the number of mechanisms for increased expression. This work generated over 10 program opportunities for internal and partnered development.